These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 1725576)
41. The antibody/antiserum as an analytical reagent in quantitative immunoassays. Albert WH Scand J Clin Lab Invest Suppl; 1991; 205():79-85. PubMed ID: 1947752 [TBL] [Abstract][Full Text] [Related]
42. Standardization of ceruloplasmin measurements is still an issue despite the availability of a common reference material. Infusino I; Valente C; Dolci A; Panteghini M Anal Bioanal Chem; 2010 May; 397(2):521-5. PubMed ID: 19921156 [TBL] [Abstract][Full Text] [Related]
43. Standardization of hormone determinations. Stenman UH Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):823-30. PubMed ID: 24275193 [TBL] [Abstract][Full Text] [Related]
45. Antibody quantitation in human and veterinary medicine. Masseyeff RF Scand J Clin Lab Invest Suppl; 1991; 205():63-9. PubMed ID: 1947750 [TBL] [Abstract][Full Text] [Related]
46. Calibration is the key to immunoassay but the ideal calibrator is unattainable. Whicher JT Scand J Clin Lab Invest Suppl; 1991; 205():21-32. PubMed ID: 1947745 [TBL] [Abstract][Full Text] [Related]
48. Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value. Clerico A; Ripoli A; Zucchelli GC; Plebani M Clin Chem Lab Med; 2015 Feb; 53(3):377-82. PubMed ID: 25241732 [TBL] [Abstract][Full Text] [Related]
49. Measurement signal versus value in immunoassays for human plasmaproteins. Baudner S Scand J Clin Lab Invest Suppl; 1991; 205():70-8. PubMed ID: 1947751 [TBL] [Abstract][Full Text] [Related]
50. Ultra-specific immunoassays for small molecules: roles of wash steps and multiple binding formats. Self CH; Dessi JL; Winger LA Clin Chem; 1996 Sep; 42(9):1527-31. PubMed ID: 8787724 [TBL] [Abstract][Full Text] [Related]
51. Quality control of antibodies for assay development. Schumacher S; Seitz H N Biotechnol; 2016 Sep; 33(5 Pt A):544-50. PubMed ID: 26873787 [TBL] [Abstract][Full Text] [Related]
52. Approaches to minimizing interference by cross-reacting molecules in immunoassays. Miller JJ; Valdes R Clin Chem; 1991 Feb; 37(2):144-53. PubMed ID: 1993317 [TBL] [Abstract][Full Text] [Related]
53. Why do immunoassays for tumour markers give differing results?--a view from the UK National External Quality Assessment Schemes. Sturgeon CM; Seth J Eur J Clin Chem Clin Biochem; 1996 Sep; 34(9):755-9. PubMed ID: 8891529 [TBL] [Abstract][Full Text] [Related]
54. Antibodies for immunoassays. Newman DJ Methods Mol Med; 2000; 40():209-25. PubMed ID: 21337092 [TBL] [Abstract][Full Text] [Related]
55. Standardization and calibration of cytokine immunoassays: meeting report and recommendations. Wadhwa M; Thorpe R Cytokine; 1997 Nov; 9(11):791-3. PubMed ID: 9367538 [No Abstract] [Full Text] [Related]
56. Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment. Bautista AC; Wullner D; Moxness M; Swanson SJ; Chirmule N; Jawa V Bioanalysis; 2010 Apr; 2(4):721-31. PubMed ID: 21083270 [TBL] [Abstract][Full Text] [Related]
57. Immunoassay: recent developments and future directions. Ekins R Nucl Med Biol; 1994 Apr; 21(3):495-521. PubMed ID: 9234310 [TBL] [Abstract][Full Text] [Related]
58. Theoretical analysis of the accuracy of calibrated immunoassays for measuring antibody concentration. Griswold WR; Chalquest RR Mol Immunol; 1991 Jul; 28(7):727-32. PubMed ID: 1857350 [TBL] [Abstract][Full Text] [Related]
59. Common decision limits --The need for harmonised immunoassays. Sturgeon CM Clin Chim Acta; 2014 May; 432():122-6. PubMed ID: 24291707 [TBL] [Abstract][Full Text] [Related]
60. Immunoassays for detecting cytokines: what are they really measuring? Mire-Sluis AR; Gaines-Das R; Thorpe R J Immunol Methods; 1995 Oct; 186(2):157-60. PubMed ID: 7594615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]